What sector does Aclaris Therapeutics Inc (ACRS) operate in?
Aclaris Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Aclaris Therapeutics Inc (ACRS) current stock price?
As of the latest data, Aclaris Therapeutics Inc stock price is $2.67, with a previous close of $2.74. Aclaris Therapeutics Inc lost -$0.07 in the last trading session, representing a -2.55% loss.
What is Aclaris Therapeutics Inc (ACRS) current market capitalization?
Aclaris Therapeutics Inc market cap is approximately 289.25 million.
What is Aclaris Therapeutics Inc (ACRS) Earnings Per Share (EPS)?
The trailing EPS is -$1.57, and the forward EPS is -$0.62.
What is Aclaris Therapeutics Inc (ACRS) EBITDA?
Aclaris Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -15.21 million.
Does Aclaris Therapeutics Inc (ACRS) pay dividends?
No. Aclaris Therapeutics Inc does not pay a dividend.
How did Aclaris Therapeutics Inc (ACRS) perform in its most recent earnings report?
In the last report (September 30, 2025), Aclaris Therapeutics Inc posted an EPS surprise of 7.14% and a revenue surprise of 38.06%.
What is Aclaris Therapeutics Inc (ACRS) beta (volatility) score?
Aclaris Therapeutics Inc has a beta of 0.275, indicating lower volatility than the overall market.